
Kirk Hevener
Associate Professor · University of Tennessee College of Medicine
Credentials: · ·
History
Research
Validation of molecular docking programs for virtual screening against dihydropteroate synthase
Journal of Chemical Information and Modeling · 2009 · First of 7 authors · 371 citations
Review · Journal of Medicinal Chemistry · 2013 · Last of 9 authors · 209 citations
Recent developments in topoisomerase-targeted cancer chemotherapy
Review · Acta Pharmaceutica Sinica B · 2018 · First of 5 authors · Corresponding · 151 citations
- KT
Kent Truong
3 papers

2 papers
- JG
2 papers

2 papers
- BE
1 paper

1 paper

1 paper
- GA
1 paper · 1 as a resident
Grants
- 2024–2029
Development of Microbiome-Sparing Antibacterials for Clostridioides Difficile Infection
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $1.5M · University of Tennessee Health Sci Ctr
- 2024–2027
National Institute of Dental and Craniofacial Research · R21
PI · $461.5K · Texas A&m University Health Science Ctr
- 2016–2019
Investigation of the FAS-II Enzyme, FabK, as a Druggable Target for C. difficile
National Institute of Allergy and Infectious Diseases · R21
Contact PI · $424.1K · University of Tennessee Health Sci Ctr
